Encision Inc. Announces Fiscal 2026 Third Quarter Results

February 4, 2026 7:00 AM

Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today reported its financial results for its 2026 fiscal third quarter. Encision's CEO Robert Fries commented, "The Company's revenue has continued to decline principally because of procedures that were performed by surgical robots that have replaced our...

Read more

Dr. Ben Barton Calls for Better Business Education in Healthcare

February 3, 2026 4:05 PM

Dr. Ben Barton, Medical Consultant and author, is raising awareness around a growing gap in healthcare: the lack of practical business education for medical professionals. Drawing on years of consulting experience and firsthand observations, Barton advocates for clearer systems, stronger operational thinking, and deeper foundational knowledge for those running medical practices."Most clinicians are trained to deliver great care," Barton says....

Read more

Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results

February 3, 2026 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced operational and financial results for the fiscal 2026 second quarter.The Company is also providing an update on its recent commercial launch of EXXUA, a novel first-in-class selective serotonin 5HT1a receptor...

Read more

Spok Earns 2026 Top Ranking for Secure Messaging and Clinical Communications in Black Book Annual Client Experience Survey for the Ninth Consecutive Year

February 3, 2026 4:00 PM

Black Book™, the independent healthcare IT research firm, today released its 2026 rankings for secure messaging, HIPAA-compliant texting, and clinical communications solutions based on verified client experience. The study, fielded Q4 2025 through Q1 2026, includes 1,416 validated provider-organization responses-an 11% increase in participation versus the prior year.In the 2026 results, Spok® was ranked the overall #1 market leader. Spok posted...

Read more

Mercury Medical Awarded Vizient Contract for Disposable Manual Resuscitators and Accessories

February 3, 2026 10:00 AM

Mercury Medical, headquartered in Clearwater, Florida, is pleased to announce that it has been awarded a Vizient® contract for Disposable Manual Resuscitators and Accessories. The agreement is effective February 1, 2026, and provides Vizient client hospitals and health systems enhanced access, at their discretion, to pre-negotiated pricing and terms for Mercury Medical's clinically differentiated resuscitation portfolio.Vizient clients will have...

Read more

viemaa Haircare Launches at CVS Pharmacy: Where Science Meets Style(TM)

February 3, 2026 10:00 AM

viemaa, the high-performing prestige haircare brand, is now available at CVS, bringing revolutionary haircare solutions to customers nationwide. Combining science and style, viemaa introduces advanced, science-driven products designed to repair and transform hair. At the core of viemaa's philosophy is SCIENCE MEETS STYLE™. The brand's patented technology works alongside hydrolyzed pea protein-a bio-inspired ingredient that mimics the amino...

Read more

DirectTrust(R) Seeks Nominations for New Board Directors

February 3, 2026 9:30 AM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare technology and data exchange through standards, accreditation, and other services, today announced a call for nominations for new Board Directors. A volunteer position, DirectTrust's Board of Directors supports the work of the organization with mission-based leadership and strategic governance. Nominations will be accepted through March 20,...

Read more

Future-Ready EHR Vendor Rankings for Small and Critical Access Hospitals: Black Book Survey Highlights 2026 Outlook

February 3, 2026 9:00 AM

Black Book Market Research reports that rural and critical access hospitals are entering a consequential health IT decision cycle, shaped by heightened cybersecurity exposure, persistent staffing constraints, and increasing board-level oversight of sustainability and measurable outcomes. In parallel, newly announced federal Rural Health Transformation (RHT) Program awards to all 50 states are expected to accelerate modernization planning and...

Read more

Stemtech Corporation Welcomes Dr. Zahooruddin To Life Sciences Advisory Board

February 3, 2026 8:30 AM

Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to appoint Dr. Zahooruddin, MBBS (MD), DAASCP to the Life Sciences Advisory Board.(Stemtech Corporation - OTC: STEK)"Live longer - Live better - Live younger" Dr. Zahooruddin, MDPresident & COO, John W. Meyer stated "We are pleased to have Dr. Zahooruddin join the Stemtech Life Sciences Advisory Board, along with Stemtech Corporation Chief Scientific Officer,...

Read more

Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth

February 3, 2026 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced executive leadership transitions to support the Company's continued execution, drive achievement of long-term strategic objectives, and next phase of growth.Effective April 1, 2026, Marvin White, who has served as President and Chief...

Read more

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution

February 3, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), wholly owned subsidiary, Buzz Bomb Caffeine Company, today announced a strategic brand management and distribution agreement with Blue Shark Beverages. Effective February 1, the relationship is expected to drive the retail expansion of BUZZ BOMB™, a proprietary 50mg sublingual caffeine stick pack in four flavors, across key Southern California markets. The rollout will...

Read more

MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study

February 3, 2026 7:30 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics for neuropathic and inflammation-driven pain conditions, metabolic disorders, and oncology-related indications, today announced that it has initiated dosing in the final cohort of its Phase 1 multiple ascending dose (MAD) clinical trial evaluating Ketamir-2, its lead oral NMDA receptor antagonist.To date,...

Read more

CBD Life Sciences Inc. (CBDL) Announces Smoking Scholars Bronx Dispensary as Major Distributor for High-Demand Dubai Mushroom Chocolate

February 3, 2026 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), a fast-growing wellness and cannabinoid company focused on premium, trend-driven consumer products, today announced that Smoking Scholars, a well-established dispensary located in the Bronx, New York, has expanded its relationship with the Company to become a major distributor of CBDL's Dubai Mushroom Chocolate - one of the most in-demand functional wellness confections currently gaining traction across...

Read more

AlzeCure Abstract on NeuroRestore ACD856 accepted at the Alzheimer's conference AP/PD 2026

February 3, 2026 4:15 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that an abstract with preclinical data on NeuroRestore ACD856 which examines in more detail the biological effects of the substance mediated by its mechanism of action has been accepted for presentation at the international...

Read more

The Micro-Mechanics of Modern Oral Care

February 2, 2026 2:30 PM

Quality Dental Services functions as a foundational component supplier within the dental industry, sustaining the mechanical integrity of clinical handpieces through precision bearings, turbines, and engineered subassemblies. By bridging the widening gap between high-cost original equipment manufacturer components and rigorously vetted aftermarket solutions, the company has contributed to stabilizing the long-term economics of dental practice...

Read more

Rising Pet Asthma Costs Drive Demand for Flovent Coupons and Lower Inhaler Prices

February 2, 2026 12:00 PM

Veterinarians commonly treat feline asthma with inhaled corticosteroids to reduce airway inflammation, and fluticasone propionate is one of the best-known options. Cornell University's Feline Health Center estimates that asthma affects about 1% to 5% of cats, a prevalence that leaves many households facing long-term respiratory care and repeat prescription refills.Industry data underscores the financial backdrop. The American Pet Products...

Read more

Rural Health Transformation Reality Check: What Rural Hospital Decision-Makers Will Fund in 2026 and What They Won't

February 2, 2026 9:50 AM

Ahead of the AHA Rural Health Care Leadership Conference (Feb. 8-11, San Antonio), Black Book Market Research today released findings from its Q1 2026 Rural Transformation Readiness Survey of rural, small, and critical access hospitals (CAHs). The results show a decisive shift from feature-first purchasing to delivery certainty: execution capacity, auditable outcomes, cybersecurity resilience, integration scope clarity, interoperability...

Read more

NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres

February 2, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that our President Dr. Anil R. Diwan was interviewed on the Mission Matters Podcast by Mr. Adam Torres. The interview video is available at https://youtu.be/nU_2dgd-u1g.Mr. Torres began with asking what is the mission of NanoViricides. Dr. Diwan responded that...

Read more

AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam

February 2, 2026 7:15 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company has been selected to present at Bio‑Neuroscience 2026, an international partnering and investor conference in neuroscience, taking place in Amsterdam, the Netherlands, on February 24-26, 2026.Bio-Neuroscience is a world-leading...

Read more

NHI Announces $105.5 Million SHOP Investment

February 2, 2026 6:00 AM

National Health Investors, Inc. (NYSE:NHI) announced today that it invested $105.5 million, including transaction costs, for the acquisition of nine properties with 460 units in Kentucky, South Carolina and Tennessee. NHI expects to make an additional investment of $3.3 million during the first year.The properties and healthcare operations will be included in NHI's Senior Housing Operating Portfolio ("SHOP") segment and will be managed by...

Read more